(1)
Ortigosa, L. C.; Silva, L. C.; Duarte, A. J.; Takahashi, M. D.; Benard, G. Infliximab Does Not Lead to Reduction in the Interferon-Gamma and Lymphoproliferative Responses of Patients With Moderate to Severe Psoriasis. Acta Derm Venereol 2013, 94, 26-31.